Greatanalysis matching up Dr. Ngo’s heart damaging cancer drugs study with thosedrugs reported by RAC as showing cardio-protection and cancer killing synergy.
I note there are two drugs on the list that RAC has announced cancer killing synergy, but not cardio-protection, with. Hopefully, this will mean that bisantrene will also be found to be cardio-protective with:
- Epirubicin - the cancer killing synergy was announced as part of the anthracycline synergy study reported on 22November 2021 - https://hotcopper.com.au/threads/ann-breakthrough-zantrene-heart-protection-discovery.6435902/- Olaparib - the cancer killing synergy was announced as part of the MD Anderson study reported on 23 February 2022 - https://hotcopper.com.au/threads/ann-md-anderson-preclinical-aml-study-on-zantrene-published.6600203/
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-221
- There are more pages in this discussion • 334 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.005(0.34%) |
Mkt cap ! $242.5M |
Open | High | Low | Value | Volume |
$1.46 | $1.50 | $1.43 | $62.91K | 43.17K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5700 | $1.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 591 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5700 | 1.430 |
3 | 13542 | 1.420 |
2 | 20700 | 1.410 |
1 | 3500 | 1.405 |
6 | 25737 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 591 | 1 |
1.500 | 7000 | 1 |
1.510 | 2408 | 1 |
1.540 | 10000 | 1 |
1.550 | 26171 | 3 |
Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.46 |
  |
Change
-0.005 ( 0.23 %) |
|||
Open | High | Low | Volume | ||
$1.44 | $1.49 | $1.43 | 9034 | ||
Last updated 13.08pm 24/05/2024 ? |
Featured News
RAC (ASX) Chart |